Armata Pharmaceuticals, Inc. (ARMP) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $8.39 (-8.25%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
ARMP vs Sector & Market
| Metric | ARMP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +78.7% | +1710.9% | +16.4% |
| P/E Ratio | -2.04 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1M | $1M | $1M | 1 |
| 2026-09-30 | $1M | $1M | $1M | 1 |
| 2026-12-31 | $1M | $1M | $1M | 1 |
| 2027-12-31 | $6M | $6M | $6M | 1 |
| 2028-12-31 | $56M | $56M | $56M | 1 |
| 2029-12-31 | $19M | $19M | $19M | 1 |
| 2030-12-31 | $57M | $57M | $57M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.39 | $-0.39 | $-0.39 | 1 |
| 2026-09-30 | $-0.23 | $-0.23 | $-0.23 | 1 |
| 2026-12-31 | $-0.25 | $-0.25 | $-0.25 | 1 |
| 2027-12-31 | $-0.93 | $-0.93 | $-0.93 | 1 |
| 2028-12-31 | $-0.95 | $-0.95 | $-0.95 | 1 |
| 2029-12-31 | $-0.56 | $-0.56 | $-0.56 | 1 |
| 2030-12-31 | $-0.10 | $-0.10 | $-0.10 | 1 |
Frequently Asked Questions
What is the analyst consensus for ARMP?
The consensus among 1 analysts covering Armata Pharmaceuticals, Inc. (ARMP) is Buy with an average price target of $15.00.
What is the highest price target for ARMP?
The highest analyst price target for ARMP is $15.00.
What is the lowest price target for ARMP?
The lowest analyst price target for ARMP is $15.00.
How many analysts cover ARMP?
1 analysts have issued ratings for Armata Pharmaceuticals, Inc. in the past 12 months.
Is ARMP a buy or sell right now?
Based on 1 analyst ratings, ARMP has a consensus rating of Buy (2.00/5) with a +78.7% upside to the consensus target of $15.00.
What are the earnings estimates for ARMP?
Analysts estimate ARMP will report EPS of $-0.39 for the period ending 2026-06-30, with revenue estimated at $1M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.